
Emami Q1 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 1
Fundraise
N/A
Order
N/A
Capex
Yes
2 of 3 growth signals are positive.
Full analysisRevenue guidance
Category 3- Targeting around 10% sales growth over the next 2-3 years.
- International business expected to grow at about 15% in the long term.
- Male Grooming portfolio anticipated to achieve double-digit growth from Q2 onwards.
- Healthcare segment (10-12% contribution) expected to deliver double-digit growth.
- Summer and winter portfolios' performance will influence growth; confident of 6-8% growth in Boro Plus and Navratna.
- Kesh King portfolio projected to grow around 7-8% annually over the next 2-3 years.
- Innovation-driven growth estimated at about 3% for the full year.
- Modern trade and e-commerce channels expected to grow by 15-20%, with e-commerce contribution possibly reaching 25-26% in 2-3 years.
- Rural recovery expected to further boost sales.
- Overall confident of 8-10% medium to long-term growth, supported by increased A&P investment and expanded distribution.
See what Emami management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Emami management said on order book — free account, 30 seconds.
Capex plans
YesTrack Emami — get its next earnings analysis in your feed
How does Emami rank vs peers in Personal Products?
Pro featureHow does Emami rank in Personal Products?
Compare Emami against every Personal Products company (Q1 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Emami's management said in earlier quarters
Others in Personal Products this season
- Anondita Medicare (Q2 FY27)
Revenue (Standalone)** for H1 FY27: ₹5,786.31 Lakhs, up 21.43% YoY from ₹4,765.06 Lakhs in H1 FY26 . Key investor presentation takeaways from Anondita Medicare
- Gillette India (Q2 FY27)
Revenue from operations for the quarter ended 30th September 2026: ₹84,610 lakh (Page 3) . Key results statement takeaways from Gillette India Ltd's Q2 FY27 ear
- Cupid (Q2 FY27)
Q2 FY27 revenue from operations: ₹187.86 Crores, up 122.5% YoY (Q2 FY26: ₹84.45 Crores) [Page 14, 16] . Key investor presentation takeaways from Cupid Ltd's Q2
- Honasa Consumer (Q2 FY27)
Younger brands, excluding The Derma Co., are growing healthily at 40%+ year-on-year, with the overall portfolio showing strong momentum across online and…